Reviva Pharmaceuticals Holdings, Inc.RVPHNASDAQ
Loading
Interest Expense Over TimeContracting
Percentile Rank29
3Y CAGR-49.4%
5Y CAGR-56.1%
Studio
Year-over-Year Change

Interest expense on outstanding debt

3Y CAGR
-49.4%/yr
vs -24.3%/yr prior
5Y CAGR
-56.1%/yr
Recent acceleration
Acceleration
-25.0pp
Decelerating
Percentile
P29
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
TTM$23733.00+28.3%
2024$18497.00-45.2%
2023$33725.00-81.6%
2022$182802.00+7472.6%
2021$2414.00-99.8%
2020$1.45M+209.6%
2019$469373.00-15.8%
2018$557675.00-